Interplay of Three G-Quadruplex Units in the KIT Promoter.


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
03 07 2019
Historique:
pubmed: 28 6 2019
medline: 23 9 2020
entrez: 28 6 2019
Statut: ppublish

Résumé

The proto-oncogene KIT encodes for a tyrosine kinase receptor, which is a clinically validated target for treating gastrointestinal stromal tumors. The KIT promoter contains a G-rich domain within a relatively long sequence potentially able to form three adjacent G-quadruplex (G4) units, namely, K2, SP, and K1. These G4 domains have been studied mainly as single quadruplex units derived from short truncated sequences and are currently considered promising targets for anticancer drugs, alternatively to the encoded protein. Nevertheless, the information reported so far does not contemplate the interplay between those neighboring G4s in the context of the whole promoter, possibly thwarting drug-discovery efforts. Here we report the structural and functional study of the KIT promoter core sequence, in both single- and double-stranded forms, which includes all three predicted G4 units. By preventing the formation of alternatively one or two G4 units and by combining biophysical techniques and biological assays, we show for the first time that these quadruplexes cannot be analyzed independently, but they are correlated to each other. Our data suggest that, while K2 and K1 G-rich sequences retain the ability to fold into parallel G4 motifs within a long sequence, the SP G-rich domain contributes to G4 structure only together with K2. Remarkably, we have found that, in the context of a dynamic equilibrium between the three G4 units, the G4 formed by K1 has the most significant influence on the structure stability and on the biological role of the whole promoter.

Identifiants

pubmed: 31244182
doi: 10.1021/jacs.8b12753
doi:

Substances chimiques

MAS1 protein, human 0
Proto-Oncogene Mas 0
Proto-Oncogene Proteins c-kit EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10205-10213

Auteurs

Cosimo Ducani (C)

Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm 171 65 , Sweden.

Giulio Bernardinelli (G)

Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm 171 65 , Sweden.

Björn Högberg (B)

Department of Medical Biochemistry and Biophysics , Karolinska Institutet , Stockholm 171 65 , Sweden.

Bernhard K Keppler (BK)

Institute of Inorganic Chemistry , University of Vienna , Waehringerstrasse 42 , A-1090 Vienna , Austria.

Alessio Terenzi (A)

Institute of Inorganic Chemistry , University of Vienna , Waehringerstrasse 42 , A-1090 Vienna , Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH